bisoprolol has been researched along with Electrocardiogram QT Prolonged in 7 studies
Bisoprolol: A cardioselective beta-1 adrenergic blocker. It is effective in the management of HYPERTENSION and ANGINA PECTORIS.
Excerpt | Relevance | Reference |
---|---|---|
" We describe two cases where a switch to bisoprolol resulted in worsening of arrhythmia control: A man with LQT2, asymptomatic on propranolol, experienced syncope after switching to bisoprolol 5 mg daily." | 7.83 | Two Cases of LQT Syndrome with Malignant Syncope after Switch from Propranolol to Bisoprolol. ( Jensen, SM; Kesek, M; Rydberg, A, 2016) |
" We describe two cases where a switch to bisoprolol resulted in worsening of arrhythmia control: A man with LQT2, asymptomatic on propranolol, experienced syncope after switching to bisoprolol 5 mg daily." | 3.83 | Two Cases of LQT Syndrome with Malignant Syncope after Switch from Propranolol to Bisoprolol. ( Jensen, SM; Kesek, M; Rydberg, A, 2016) |
"Bisoprolol treatment results in QTc shortening in gene-positive LQT1 and LQT2 patients and is well tolerated during long-term administration." | 1.43 | Experience with bisoprolol in long-QT1 and long-QT2 syndrome. ( Adler, A; Al-Sabeq, B; Andrade, JG; Bennett, MT; Chakrabarti, S; Deyell, MW; Green, M; Kerr, CR; Klein, GJ; Krahn, AD; Laksman, ZW; Padfield, GJ; Steinberg, C; Yee, R; Yeung-Lai-Wah, JA, 2016) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (28.57) | 29.6817 |
2010's | 5 (71.43) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Higa, A | 1 |
Hoshi, H | 1 |
Yanagisawa, Y | 1 |
Ito, E | 1 |
Morisawa, G | 1 |
Imai, JI | 1 |
Watanabe, S | 1 |
Takagi, M | 1 |
Fazio, G | 1 |
Vernuccio, F | 1 |
Lo Re, G | 1 |
Grutta, G | 1 |
Mongiovì, M | 1 |
Kesek, M | 1 |
Rydberg, A | 1 |
Jensen, SM | 1 |
Steinberg, C | 1 |
Padfield, GJ | 1 |
Al-Sabeq, B | 1 |
Adler, A | 1 |
Yeung-Lai-Wah, JA | 1 |
Kerr, CR | 1 |
Deyell, MW | 1 |
Andrade, JG | 1 |
Bennett, MT | 1 |
Yee, R | 1 |
Klein, GJ | 1 |
Green, M | 1 |
Laksman, ZW | 1 |
Krahn, AD | 1 |
Chakrabarti, S | 1 |
Kuusela, J | 1 |
Kim, J | 1 |
Räsänen, E | 1 |
Aalto-Setälä, K | 1 |
Yoshiga, Y | 1 |
Shimizu, A | 1 |
Yamagata, T | 1 |
Hayano, T | 1 |
Ueyama, T | 1 |
Ohmura, M | 1 |
Itagaki, K | 1 |
Kimura, M | 1 |
Matsuzaki, M | 1 |
Dubrey, SW | 1 |
Grocott-Mason, R | 1 |
1 trial available for bisoprolol and Electrocardiogram QT Prolonged
Article | Year |
---|---|
Beta-blocker decreases the increase in QT dispersion and transmural dispersion of repolarization induced by bepridil.
Topics: Adrenergic beta-Antagonists; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Bepridil; Bisoprolol | 2002 |
6 other studies available for bisoprolol and Electrocardiogram QT Prolonged
Article | Year |
---|---|
Evaluation system for arrhythmogenic potential of drugs using human-induced pluripotent stem cell-derived cardiomyocytes and gene expression analysis.
Topics: Amlodipine; Arrhythmias, Cardiac; Benzimidazoles; Biphenyl Compounds; Bisoprolol; Cardiotoxicity; Ce | 2017 |
Role of bisoprolol in patients with long QT syndrome.
Topics: Adolescent; Adrenergic beta-1 Receptor Antagonists; Adult; Bisoprolol; Child; Electrocardiography; E | 2013 |
Two Cases of LQT Syndrome with Malignant Syncope after Switch from Propranolol to Bisoprolol.
Topics: Anti-Arrhythmia Agents; Antihypertensive Agents; Bisoprolol; Drug Administration Schedule; Humans; L | 2016 |
Experience with bisoprolol in long-QT1 and long-QT2 syndrome.
Topics: Adrenergic beta-1 Receptor Antagonists; Adult; Bisoprolol; Canada; Cardiotonic Agents; Cohort Studie | 2016 |
The Effects of Pharmacological Compounds on Beat Rate Variations in Human Long QT-Syndrome Cardiomyocytes.
Topics: Adrenergic beta-1 Receptor Antagonists; Adult; Bisoprolol; Cells, Cultured; Dose-Response Relationsh | 2016 |
Drug-induced QT prolongation: consequences and current dilemma.
Topics: Aged, 80 and over; Anti-Arrhythmia Agents; Bisoprolol; Electrocardiography; Female; Humans; Long QT | 2007 |